摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-aminonitrobenzoimidazolol | 691353-57-8

中文名称
——
中文别名
——
英文名称
3-aminonitrobenzoimidazolol
英文别名
1-hydroxy-2-(3-Amino-phenyl)-6-nitro benzoimidazole;3-(1-Hydroxy-6-nitrobenzimidazol-2-yl)aniline
3-aminonitrobenzoimidazolol化学式
CAS
691353-57-8
化学式
C13H10N4O3
mdl
——
分子量
270.247
InChiKey
OMVQXLLBYSUHFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    110
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Transcription factor modulating compounds and methods of use thereof
    摘要:
    提供了作为抗感染剂有用的取代苯并咪唑化合物,可以降低微生物的抗药性、毒力或生长。提供了制备和使用取代苯并咪唑化合物的方法,以及其制药制剂,例如,用于降低抗生素抗性和抑制生物膜。
    公开号:
    US20060160799A1
  • 作为产物:
    描述:
    3-氨基苄胺 在 sodium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 3-aminonitrobenzoimidazolol
    参考文献:
    名称:
    Novel anti-infection agents: Small-molecule inhibitors of bacterial transcription factors
    摘要:
    Structure-based drug design was utilized to identify potent small-molecule inhibitors of proteins within the AraC family of bacterial transcription factors, which control virulence in medically important microbes. These agents represent a novel approach to fight infectious disease and may be less likely to promote resistance development. These compounds lack intrinsic antibacterial activity in vitro and were able to limit a bacterial infection in a mouse model of urinary tract infection. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.07.072
点击查看最新优质反应信息

文献信息

  • Transcription Factor Modulating Compounds and Methods of Use Thereof
    申请人:Alekshun Michael N.
    公开号:US20090131481A1
    公开(公告)日:2009-05-21
    Substituted benzimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of using substituted benzimidazole compounds, in, e.g., reducing virulence and infectivity, inhibiting biofilms and treating bacterial infections are also provided.
    提供了一种有用的取代苯并咪唑化合物,可用作抗感染剂,降低微生物的抗药性、毒力或生长。还提供了使用取代苯并咪唑化合物的方法,例如减少病原体的毒力和感染性、抑制生物膜和治疗细菌感染。
  • US7405235B2
    申请人:——
    公开号:US7405235B2
    公开(公告)日:2008-07-29
  • [EN] TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS MODULANT LE FACTEUR DE TRANSCRIPTION ET LEURS PROCÉDÉS D'UTILISATION
    申请人:PARATEK PHARM INNC
    公开号:WO2009005551A2
    公开(公告)日:2009-01-08
    Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of using substituted benzimidazole compounds, in, e.g., reducing virulence and infectivity, inhibiting biofilms and treating bacterial infections.
  • Transcription factor modulating compounds and methods of use thereof
    申请人:Alekshun N. Michael
    公开号:US20060160799A1
    公开(公告)日:2006-07-20
    Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.
    提供了作为抗感染剂有用的取代苯并咪唑化合物,可以降低微生物的抗药性、毒力或生长。提供了制备和使用取代苯并咪唑化合物的方法,以及其制药制剂,例如,用于降低抗生素抗性和抑制生物膜。
  • Novel anti-infection agents: Small-molecule inhibitors of bacterial transcription factors
    作者:Todd E. Bowser、Victoria J. Bartlett、Mark C. Grier、Atul K. Verma、Taduesz Warchol、Stuart B. Levy、Michael N. Alekshun
    DOI:10.1016/j.bmcl.2007.07.072
    日期:2007.10
    Structure-based drug design was utilized to identify potent small-molecule inhibitors of proteins within the AraC family of bacterial transcription factors, which control virulence in medically important microbes. These agents represent a novel approach to fight infectious disease and may be less likely to promote resistance development. These compounds lack intrinsic antibacterial activity in vitro and were able to limit a bacterial infection in a mouse model of urinary tract infection. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多